Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including β-lactamase-producing and vancomycin-resistant isolates
dc.contributor.author | Arias, César A. | |
dc.contributor.author | Singh, Kavindra V. | |
dc.contributor.author | Panesso, Diana | |
dc.contributor.author | Beral, Valerie | |
dc.contributor.orcid | Panesso, Diana [0000-0002-4049-9702] | |
dc.date.accessioned | 2020-08-20T19:21:25Z | |
dc.date.available | 2020-08-20T19:21:25Z | |
dc.date.issued | 2007 | |
dc.description.abstractenglish | Ceftobiprole (BAL9141) is an investigational cephalosporin with broad in vitro activity against gram-positive cocci, including enterococci. Ceftobiprole MICs were determined for 93 isolates of Enterococcus faecalis (including 16 β-lactamase [Bla] producers and 17 vancomycin-resistant isolates) by an agar dilution method following the Clinical and Laboratory Standards Institute recommendations. Ceftobiprole MICs were also determined with a high inoculum concentration (107 CFU/ml) for a subset of five Bla producers belonging to different previously characterized clones by a broth dilution method. Time-kill and synergism studies (with either streptomycin or gentamicin) were performed with two β-lactamase-producing isolates (TX0630 and TX5070) and two vancomycin-resistant isolates (TX2484 [VanB] and TX2784 [VanA]). The MICs of ceftobiprole for 50 and 90% of the isolates tested were 0.25 and 1 μg/ml, respectively. All Bla producers and vancomycin-resistant isolates were inhibited by concentrations of ≤1 and ≤4 μg/ml, respectively, at the standard inoculum concentration. Ceftobiprole MICs at a high inoculum concentration for a subset of five Bla+E. faecalis isolates were ≤1 μg/ml. Bactericidal activity was observed against four isolates tested at concentrations as low as 1 μg/ml regardless of the production of β-lactamase or vancomycin resistance. A combination of ceftobiprole (0.5 μg/ml) and streptomycin (25 μg/ml) was synergistic against Bla+ TX0630 and TX5070. Ceftobiprole (0.5 μg/ml) plus gentamicin (10 μg/ml) was synergistic against VanB isolate TX2484 and showed enhanced killing, but not synergism, against TX2784 (VanA), despite the absence of high-level resistance to gentamicin. In conclusion, ceftobiprole exhibited good in vitro activity against E. faecalis, including Bla+ and vancomycin-resistant strains, and exhibited synergism with aminoglycosides against selected isolates. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://dx.doi.org/10.1128%2FAAC.00131-07 | |
dc.identifier.instname | instname:Universidad El Bosque | spa |
dc.identifier.issn | 1098-6596 | |
dc.identifier.reponame | reponame:Repositorio Institucional Universidad El Bosque | spa |
dc.identifier.repourl | https://repositorio.unbosque.edu.co | |
dc.identifier.uri | https://hdl.handle.net/20.500.12495/3824 | |
dc.language.iso | eng | |
dc.publisher | American Society for Microbiology | spa |
dc.publisher.journal | Antimicrobial agents and chemotherapy | spa |
dc.relation.ispartofseries | Antimicrobial agents and chemotherapy, 1098-6596, Vol. 51, Nro. 6, 2007, p. 2043-2047 | spa |
dc.relation.uri | https://aac.asm.org/content/51/6/2043.short | |
dc.rights.accessrights | https://purl.org/coar/access_right/c_abf2 | |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
dc.rights.accessrights | Acceso abierto | |
dc.rights.creativecommons | 2007-04-05 | |
dc.rights.local | Acceso abierto | spa |
dc.subject.decs | Enterococcus faecalis | spa |
dc.subject.decs | beta-Lactamasas | spa |
dc.subject.decs | Ampicilina | spa |
dc.title | Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including β-lactamase-producing and vancomycin-resistant isolates | spa |
dc.title.translated | Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including β-lactamase-producing and vancomycin-resistant isolates | spa |
dc.type.coar | https://purl.org/coar/resource_type/c_6501 | |
dc.type.driver | info:eu-repo/semantics/article | |
dc.type.hasversion | info:eu-repo/semantics/publishedVersion | |
dc.type.local | Artículo de revista |
Archivos
Bloque original
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- Cesar A. Arias, Kavindra V. Singh_2007.pdf
- Tamaño:
- 155.44 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: